Positions

Position Company Period
Chairman of the Board X4 Pharmaceuticals Inc March 13, 2019 -
Chief Financial Officer, Executive Vice President - Finance Genzyme Corp Nov. 1, 2008 -
Director LogicBio Therapeutics Inc Dec. 6, 2018 -
Independent Director OncoMed Pharmaceuticals Inc Oct. 14, 2013 -
Independent Director Exact Sciences Corp Feb. 9, 2015 -
Independent Director Gensight Biologics SA None -
Independent Director Akebia Therapeutics Inc Jan. 1, 2014 - Dec. 12, 2018
Independent Director Idenix Pharmaceuticals LLC March 1, 2012 - Aug. 5, 2014
President, Chief Executive Officer, Director Radius Health Inc Dec. 5, 2011 - Nov. 11, 2013
Michael Wyzga's trades of X4 Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-08-22 2023-08-18 B Purchase
25,000 +48.4%
1.20
USD 29,875
25,000 +48.4% 1.20 USD 29,875
2021-03-02 2021-02-26 PS Planned sale
19,021 -88.1%
130.11
USD 2,474,822
19,021 -88.1% 130.11 USD 2,474,822
2019-03-01 2019-02-28 PS Planned sale
500 -5.5%
96.00
USD 48,000
500 -5.5% 96.00 USD 48,000
2018-05-11 2018-05-10 PS Planned sale
7,402 -40.3%
51.53
USD 381,447
7,402 -40.3% 51.53 USD 381,447
// ... existing code ... // ... rest of the file ...